By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
Novel device MacroFLUX™ that integrates absorption chamber into USP 2 dissolution bath was used to demonstrate that differences in bioequivalence study between benchmark brand name drug and its generic formulation could have been quantitatively predicted by comparing flux measurements for these formulations.